Quality and compliance, customer service levels, financials, health and safety, and environmental sustainability are key to multi-modality manufacturing success, Novartis says.

With limited assets, startups must rely on CDMO partners. And working with the right ones is imperative even if it comes with a cost.

The overall goal is to work towards a common way of innovating to increase sustainability measures, says firm.

If your CDMO is not willing to change for you then it is time to find someone else, says experts at Biotech Week Boston.

Synthetic biology could be used to develop a new paradigm in controlling cellular function and specificity, says a bioprocess engineer.

To implement transformation successfully in your company, you must start with the person and not with the technology, says GSK.